Industries

Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

2023 Global Life Sciences Summit

Research to Reality: Transformation in Life Sciences

Date: May 16th & May 17th
Live Event: 9:00 AM – 12:00 PM EDT
Replay: 9:00 PM – 12 AM EDT

EVENT HIGHLIGHTS

The transformation of the life sciences industry by AI and Chat GPT

Throughout the 2023 Global Life Sciences Summit, the unprecedented power of artificial intelligence (AI) and Chat GPT was an important talking point for our panelists. Here, listen to top thought leaders in the industry discuss how AI and Chat CPT are leading to revolutionary discoveries and innovative treatments and the imperative to mitigate potential risks and address ethical challenges that arise as we harness AI's potential. 

Session Video Highlights from the Summit

Event Summary
How KPMG can help: Precision Medicine

KPMG hosted the third annual Global Life Sciences Summit on May 16 and 17, 2023, covering the most immediate and topical issues facing life sciences executives on their transformation journey. In the thriving life sciences industry, inclusive and digital health takes center stage and defines corporate purpose. This is driven by changing patient needs, demand for skilled talent, and emerging technology.

This years’ Summit brought together founders, pioneers and innovators from the top organizations and companies around the world to collaborate on the future of the pharmaceutical, biomedical, and medical device industries and examine the changes happening in the field. More than 1500 industry experts and KPMG leaders joined this summit discussing the future of life sciences from an industrial and economic standpoint.

Highlights included discussions on the expanding role of Artificial Intelligence and Chat GPT, the FTC Anti-Trust battle with tech giants like Facebook,  modern ESG solutions and responsible sourcing, exciting innovations in women’s health amidst the growth of women working in technology, data privacy and how it affects patient safety, the role of Precision Medicine in advanced treatment of diseases like cancer and dementia, and a deep dive into Avalon, the world’s first healthcare Metaverse.

Set on a virtual platform over two days and six sessions, this dynamic and inspirational event allowed participants to share different perspectives, explore new approaches and gain invaluable insights. The sessions include pre-recorded “fire-side chats” along with a live chat function, providing the opportunity for attendees to engage in Q & A with KPMG’s subject matter experts during the live viewing.

Explore more

Agenda

 Tuesday, May 16th 2023

Masters of Ceremony: Anna Marie Detert, Partner, Healthcare and Life Sciences, KPMG UK 

                                         Guillaume Favier, Strategy Partner, Healthcare and Life Sciences, KPMG UK

Time
SessionSpeaker(s)KPMG Host

9:00 am – 9:55 am

Session 1: Industry and Economic Outlook

 

1A: Healthcare Outlook

Anna van Poucke, Global Head of Healthcare at KPMG International
 

1B: Economic Outlook

Yael Selfin, Chief Economist, KPMG UK
 1C: Digital Healthcare Solutions

Dr. Alexander Condoleon, Vice President, Head of Digital Healthcare, Sanofi

Alison Little, Principal, Advisory KPMG US

10:00 – 10:55 a.m.

Session 2: Deals, M & A, Alliances

 

2A: Connectivity, Trust, Collaboration – a new way for partnerships

Jean-Christophe Tellier, CEO at UCB

 

 

Kristin Pothier, Global Life Sciences Deal Advisory and Strategy Leader, KPMG US

 

 

2B:  FTC Antitrust Battle with Facebook and the impact on future deals in Life Sciences

Arman Oruc, Partner at Goodwin, Co-Chair, Anti-Trust, Goodwin

Jeff Stoll, PhD, Partner, National Leader Life Sciences, Strategy Consulting, KPMG US

 

11:00 - 11:55 a.m.

Session 3: Advancing ESG Solutions: Initiatives to Support the Health of People and Planet

 

3A: Women in Technology

Michelle Greene, Executive Vice President and Chief Information Officer, Cardinal HealthFiona Thomas, Chief Medical Officer, KPMG UK

 

3B: Women’s Health Innovation

Dr. Sandy Milligan, Head of Research and Development, OrganonFiona ThomasChief Medical Officer, KPMG UK

 

3C: Responsible Sourcing

Kevin Nelson, SVP & CPO, Becton Dickinson

Blythe Chorn, Managing Director, Consulting, ESG Leader, KPMG US

 3D: Health Equity

Rady Johnson, Chief Compliance, Quality & Risk Officer, Pfizer, Inc.

Melissa Taylor, Partner, Audit, KPMG US

 

Wednesday, May 17th 2023

TimeSessionSpeaker(s)KPMG Host

9:00 am – 9:55 am

Session 4: Data Science and Technology

 

4A: Data as an asset: Explore how creating a data asset enables competitive differentiation and strategic advantage

Rachel Lin, Regional Commercial Director, Janssen Asia Pacific

Freddie Yi Yu, Director & Data Scientist, Janssen Asia Pacific

Thomas Halliday, LifeScience & Healthcare, Customer Vertical Leader, Clarivate

Anastasia Miros, Director, Healthcare and Life Sciences, KPMG Asia Pacific
 

4B:  Customer and employee digital transformation

Hank Yang, Managing Director, Healthcare and Life Sciences, KPMG US

Roni Kopelman, Managing Director, Human Capital Advisory, KPMG US

 4C: Avalon: The world's first healthcare metaverseShafi Ahmed, Chief Medical Officer, Medical Realities

Justin Hoss, Principal Advisory, KPMG US

10:00 – 10:55 a.m.

Session 5: Connected Enterprise

 

5A: Data privacyBrian Cincera, SVP & Chief Information Security Officer, Pfizer, Inc.Caroline Rivett, Cyber in Life Sciences Global Lead, KPMG, UK
 

5B: Innovation in Compliance

John Gitas, Principal, Advisory, Forensic, KPMG US
Jordan Seiferas, Managing Director, Analytics and AI, KPMG US 

Matthew Colford, Director, Healthcare and Life Sciences Advisory, KPMG US 

 5C: Patient Safety and Quality

Steve C de Baca, Chief Patient Safety and Quality Officer, Philips

Rajesh Misra, Principal, Life Sciences Operations Advisory, KPMG US

11:00 am – 11:55 am

Session 6: Future of Life Sciences

 

6A: Roadblocks on the path to Precision Medicine

Luca Dezzani, VP US Oncology Medical Affairs, Johnson & Johnson

Terri Conneran, Lung Cancer Survivor, KRAS Kickers

Alasdair Milton, Managing Director, Healthcare & Life Sciences, KPMG US

 

6B: The role of the patient in the evolving patient journey of Precision Medicine in Neurodegenerative Diseases

Pearl Pugh, President, Neuroscience, Johnson & Johnson

Dr. Howard Fillit, Co-Founder and Chief Science Officer at the Alzheimer's Drug Discovery Foundation

Varun Renjen, MD Managing Director, Life Sciences Deal Advisory and Strategy, KPMG US
SPEAKERS

Guest Speakers

Shafi Ahmed
Chief Medical Officer, Medical Realities

Brian Cincera
SVP & Chief Information Security Officer, Pfizer, Inc.

Dr. Alexander Condoleon
Vice President, Head of Digital Healthcare, Sanofi

Terri Conneran
Lung Cancer Survivor, Speaker and Advocate,

Steve C de Baca
Chief Patient Safety and Quality Officer, Philips

Luca Dezzani
VP US Oncology Medical Affairs, Johnson & Johnson

Dr. Howard Fillit
Co-Founder and Chief Science Officer, Alzheimer's Drug Discovery Foundation

Michelle Greene
Executive Vice President and Chief Information Officer, Cardinal Health

Thomas Halliday
LifeScience & Healthcare, Customer Vertical Leader, Clarivate

Rady Johnson
Chief Compliance, Quality & Risk Officer, Pfizer, Inc.

Rachel Lin
Regional Commercial Director, Janssen Asia Pacific

Dr. Sandy Milligan
Head of Research and Development, Organon

Kevin Nelson
Senior Vice President & CPO, Becton Dickinson

Arman Oruc
Partner, Co-Chair, Anti-Trust, Goodwin

Pearl Pugh
President, Neuroscience, Johnson & Johnson

Jean-Christophe Tellier
Chief Executive Officer, UCB

Freddie Yi Yu
Director & Data Scientist, Janssen Asia Pacific

looking back

2022 Global Life Sciences Summit

The 2022 Global Life Sciences Summit brought together industry leaders and our experts from around the world to discuss the future of the pharmaceutical, biomedical, and medical device industries. This virtual summit allowed viewers to share different perspectives and explore new approaches to help chart a future course.

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.

Headline